文献速递MDS 与骨髓增殖性肿瘤白血病

孤立性8号染色体三体的骨髓增生异常综合征:一种常伴骨髓增殖特征的骨髓增生异常综合征类型?法国骨髓增生异常综合征研究组的报告

Myelodysplastic syndrome (MDS) with isolated trisomy 8: a type of MDS frequently associated with myeloproliferative features? A report by the Groupe Francophone des Myélodysplasies.
PubMed 文献 · Br J Haematol · 2018-07-13

该回顾性研究纳入138例孤立性+8的MDS患者,39.1%具有骨髓增殖特征。MP组EZH2、ASXL1、STAG2突变更多,接受HMA者OS更低(13 vs 23个月,P=0.02),MP型对HMA反应差且生存倾向更差。

要点

  • 孤立性+8的MDS中39.1%出现骨髓增殖特征,其中28例诊断时存在、26例病程中获得。
  • MP型EZH2、ASXL1、STAG2突变率分别为33.3%、66.7%、77.8%,均高于非MP型。
  • 接受HMA的MP型患者OS为13个月 vs 非MP型23个月(P=0.02)。

核心结论

  • 骨髓增殖特征在孤立性+8的MDS中常见,MP型EZH2、ASXL1、STAG2突变更多、对HMA反应差且生存倾向更差。

研究设计与样本

  • 法国骨髓增生异常综合征研究组开展的回顾性研究,纳入138例孤立性+8且分类或重新分类为MDS(排除MDS/骨髓增殖性肿瘤)的患者。

主要发现

  • 54例(39.1%)具有骨髓增殖特征:28例诊断时存在,26例病程中获得。
  • MP型EZH2突变33.3% vs 非MP型12.0%(P=0.047),ASXL1突变66.7% vs 42.3%(P=0.048),STAG2突变77.8% vs 21.7%(P=0.006)。
  • 诊断时MP型中位无事件生存25个月、总生存27个月,非MP型分别为28个月(P=0.15)和39个月(P=0.085)。
  • 57例接受HMA的患者中,MP型OS为13个月 vs 非MP型23个月(P=0.02)。

关键数值与推荐

  • 骨髓增殖特征定义为反复出现以下之一:白细胞计数>10×10^9/l、骨髓血症(外周血幼稚粒细胞>2%且以较成熟形式为主)、可触及脾大。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Isolated trisomy 8 (+8) is a frequent cytogenetic abnormality in the myelodysplastic syndromes (MDS), but its characteristics are poorly reported. We performed a retrospective study of 138 MDS patients with isolated +8, classified or reclassified as MDS (excluding MDS/myeloproliferative neoplasm). Myeloproliferative (MP) features were defined by the repeated presence of one of the following: white blood cell count >10 × 109 /l, myelemia (presence of circulating immature granulocytes with a predominance of more mature forms) >2%, palpable splenomegaly. Fifty-four patients (39·1%) had MP features: 28 at diagnosis, 26 were acquired during evolution. MP forms had more EZH2 (33·3% vs. 12·0% in non-MP, P = 0·047), ASXL1 (66·7% vs. 42·3%, P = 0·048) and STAG2 mutations (77·8% vs. 21·7%, P = 0·006). Median event-free survival (EFS) and overall survival (OS) were 25 and 27 months for patients with MP features at diagnosis, versus 28 (P = 0·15) and 39 months (P = 0·085) for those without MP features, respectively. Among the 57 patients who received hypomethylating agent (HMA), OS was lower in MP cases (13 months vs. 23 months in non-MP cases, P = 0.02). In conclusion, MP features are frequent in MDS with isolated +8. MP forms had more EZH2, ASXL1 and STAG2 mutations, responded poorly to HMA, and tended to have poorer survival than non-MP forms.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Drevon L, Marceau A, Maarek O, et al. Myelodysplastic syndrome (MDS) with isolated trisomy 8: a type of MDS frequently associated with myeloproliferative features? A report by the Groupe Francophone des Myélodysplasies. Br J Haematol. 2018. PMID: 30004110. doi:10.1111/bjh.15490

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。